SPR719, CAS [[1384984-18-2]]

Produktübersicht

• Artikelname: SPR719, CAS [[1384984-18-2]]
• Artikelnummer: MCE-HY-12930
• Hersteller Artikelnummer: HY-12930
• Alternativnummer: MCE-HY-12930-5MG,MCE-HY-12930-10MG,MCE-HY-12930-100MG,MCE-HY-12930-25MG,MCE-HY-12930-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: VXc-486

Produktbeschreibung

SPR719 (VXc-486) is an orally active gyrase B inhibitor, with bactericidal activity. SPR719 potently inhibits multiple agent-sensitive isolates and drug-resistant isolates of Mycobacterium tuberculosis, with MICs of 0.03 to 0.30 µg/ml and 0.08 to 5.48 µg/ml, respectively. SPR719 is promising for research of lung disease caused by non-tuberculous mycobacteria (NTM)[1][2][3][4].

Produkteigenschaften

• Molekulargewicht: 428.46
• Reinheit: 99.39
• CAS Nummer: [1384984-18-2]
• Formel: C21H25FN6O3
• Target-Kategorie: Bacterial,Topoisomerase

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound